Monoclonal Antibody, Virus

Real world evaluation of the impact of two Anti-SARS-CoV-2 monoclonal antibody regimens on COVID-19 hospitalizations in older adults

Background:Proof from medical trials recommend anti-SARS-CoV-2 monoclonal antibodies (mABs) might cut back COVID-19-related hospitalizations. The aim of this research was to evaluate the actual world

by Alexander Sanchez7 Min Reading